ECSP12011678A - Metilpirrolopirimidincarboxamidas - Google Patents

Metilpirrolopirimidincarboxamidas

Info

Publication number
ECSP12011678A
ECSP12011678A ECSP12011678A ECSP12011678A EC SP12011678 A ECSP12011678 A EC SP12011678A EC SP12011678 A ECSP12011678 A EC SP12011678A EC SP12011678 A ECSP12011678 A EC SP12011678A
Authority
EC
Ecuador
Prior art keywords
methylpirrolopirimidincarboxamids
salts
compounds
stereoisomers
meanings
Prior art date
Application number
Other languages
English (en)
Inventor
Torsten Dunkern
Josef Stadlwieser
Beate Schmidt
Heiko Bernsmann
Ewald Benediktus
Andreas Pahl
Ragna Hussong
Olaf Nimz
Matthias Müller
Martin Viertelhaus
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698276&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP12011678(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of ECSP12011678A publication Critical patent/ECSP12011678A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los compuestos de fórmula (I) en donde R1, R2, R21, R22, R23, R24, Y y R3 tienen los significados como se dan en la descripción, las sales de los mismos, y los estereoisómeros de los compuestos y las sales de los mismos, son inhibidores efectivos de la fosfodiesterasa tipo 5.
ECSP12011678 2009-08-26 2012-02-15 Metilpirrolopirimidincarboxamidas ECSP12011678A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09168685 2009-08-26

Publications (1)

Publication Number Publication Date
ECSP12011678A true ECSP12011678A (es) 2012-03-30

Family

ID=41698276

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12011678 ECSP12011678A (es) 2009-08-26 2012-02-15 Metilpirrolopirimidincarboxamidas

Country Status (25)

Country Link
US (2) US8927557B2 (es)
EP (1) EP2470536B1 (es)
JP (1) JP5791606B2 (es)
KR (1) KR101762884B1 (es)
CN (1) CN102574861B (es)
AR (1) AR077898A1 (es)
AU (1) AU2010288550B2 (es)
BR (1) BR112012003616A8 (es)
CA (1) CA2771938A1 (es)
CL (1) CL2012000271A1 (es)
CO (1) CO6491110A2 (es)
EA (1) EA021103B1 (es)
EC (1) ECSP12011678A (es)
ES (1) ES2529563T3 (es)
IL (1) IL218126A (es)
MX (1) MX2012002432A (es)
MY (1) MY159031A (es)
NZ (1) NZ598777A (es)
PE (1) PE20121133A1 (es)
SG (1) SG178481A1 (es)
TN (1) TN2012000034A1 (es)
TW (1) TWI471327B (es)
UA (1) UA106628C2 (es)
WO (1) WO2011023693A1 (es)
ZA (1) ZA201200616B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010021637A1 (de) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
JP5980318B2 (ja) 2011-06-17 2016-08-31 タケダ ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体
SG11201506211RA (en) 2013-02-21 2015-09-29 Adverio Pharma Gmbh Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
JP2020097527A (ja) * 2017-03-31 2020-06-25 武田薬品工業株式会社 複素環化合物
CN107286160A (zh) * 2017-06-05 2017-10-24 毛佳婧 一种抗肝炎药物的哌啶并吡啶并吡唑‑锌配合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754260B1 (fr) * 1996-10-04 1998-10-30 Adir Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
DE60105020T2 (de) * 2000-06-07 2005-08-18 Almirall-Prodesfarma S.A. 6-phenylpyrrolopyrimidindion derivate
EP1370562A1 (en) 2001-02-14 2003-12-17 Warner-Lambert Company LLC Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
CN100374441C (zh) * 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
US20050124623A1 (en) * 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
ATE419848T1 (de) 2004-10-29 2009-01-15 Lilly Co Eli Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1
EP1858880A1 (en) * 2005-03-09 2007-11-28 Nycomed GmbH Amido-substituted 6-phenylphenanthridines
US8853224B2 (en) 2006-09-07 2014-10-07 Industrial Research Limited Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
JP4837701B2 (ja) * 2007-04-20 2011-12-14 田辺三菱製薬株式会社 医薬組成物
AR070454A1 (es) * 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden

Also Published As

Publication number Publication date
EP2470536A1 (en) 2012-07-04
TN2012000034A1 (en) 2013-09-19
KR101762884B1 (ko) 2017-07-28
BR112012003616A2 (pt) 2016-02-23
HK1169411A1 (zh) 2013-01-25
CA2771938A1 (en) 2011-03-03
JP5791606B2 (ja) 2015-10-07
AU2010288550B2 (en) 2015-01-29
US9376442B2 (en) 2016-06-28
ZA201200616B (en) 2012-10-31
CL2012000271A1 (es) 2012-08-31
MX2012002432A (es) 2012-04-11
TW201111384A (en) 2011-04-01
UA106628C2 (uk) 2014-09-25
US20120149721A1 (en) 2012-06-14
EA201200322A1 (ru) 2012-09-28
NZ598777A (en) 2013-10-25
KR20120107458A (ko) 2012-10-02
AR077898A1 (es) 2011-09-28
ES2529563T3 (es) 2015-02-23
IL218126A (en) 2015-08-31
CO6491110A2 (es) 2012-07-31
TWI471327B (zh) 2015-02-01
IL218126A0 (en) 2012-06-28
SG178481A1 (en) 2012-03-29
MY159031A (en) 2016-12-15
BR112012003616A8 (pt) 2018-02-06
WO2011023693A1 (en) 2011-03-03
US20150073001A1 (en) 2015-03-12
US8927557B2 (en) 2015-01-06
JP2013503131A (ja) 2013-01-31
EP2470536B1 (en) 2014-11-12
CN102574861B (zh) 2015-08-05
PE20121133A1 (es) 2012-08-30
EA021103B1 (ru) 2015-04-30
AU2010288550A1 (en) 2012-04-12
CN102574861A (zh) 2012-07-11

Similar Documents

Publication Publication Date Title
UY36907A (es) Nuevas carboxamidas de acción microbiocida
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
CO6551705A2 (es) Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
ECSP11010898A (es) Pirrolidina-2-carboxamidas sustituidas
ECSP10010425A (es) Pirrolopirimidincarboxamidas
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
NI200900213A (es) Pirazol amidas de ácido carboxílico útiles como microbicidas.
SV2010003617A (es) Fungicidas
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
ECSP109945A (es) Nuevos herbicidas
SV2010003475A (es) Nuevos herbicidas
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
CR20140135A (es) Nuevos derivados de aril-quinolina
ECSP11011218A (es) Herbicidas derivados de ciclopentanodiona.
MX2011010451A (es) Derivados de oxadiazol.
UA106880C2 (uk) Нові гербіциди
UY32553A (es) Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
ECSP11011245A (es) Novedosos herbicidas
UY30476A1 (es) Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones.
SV2010003501A (es) Fungicidas novedosos
NI201100139A (es) Microbiocidas nuevos.
UY32667A (es) Nuevos derivados de furano espiroheterocíclico y tiofuranodiona
ECSP12011678A (es) Metilpirrolopirimidincarboxamidas
ECSP099738A (es) Derivados de pirazolona como inhibidores de pde4